Second-line rituximab, lenalidomide, and bendamustine in mantle cell lymphoma: a phase II clinical trial of the Fondazione Italiana Linfomi.

ABSTRACT:

SUBMITTER: Zaja F 

PROVIDER: S-EPMC5477625 | biostudies-literature | 2017 May

REPOSITORIES: biostudies-literature